nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Gap in Disease-Specific Survival Between Younger and Older Adults With De Novo Metastatic Renal Cell Carcinoma: Results of a SEER Database Analysis
|
Nelson, Rebecca A. |
|
2013 |
11 |
3 |
p. 303-310 8 p. |
artikel |
2 |
A New Sign for Detection of Extracapsular Extension of Prostatic Adenocarcinoma: Sum of Positive Sextants per Lobe Combining Interpretation of Magnetic Resonance Imaging and Prostate Biopsy Results
|
Luyckx, François |
|
2013 |
11 |
3 |
p. 256-262 7 p. |
artikel |
3 |
Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of a Compassionate Use Program in The Netherlands
|
Wissing, Michel D. |
|
2013 |
11 |
3 |
p. 238-250.e1 2263 p. |
artikel |
4 |
Curability of Poor-Risk Metastatic Sarcomatoid Renal Cell Carcinoma with the Combination of Gemcitabine, 5-Fluorouracil, and Interferon-Alfa: A Case Report of a 55-Year-Old Man with a 10-Year Complete Remission
|
Conter, Henry J. |
|
2013 |
11 |
3 |
p. 370-373 4 p. |
artikel |
5 |
Dramatic and Prolonged PSA Response After Retreatment With a PSA Vaccine
|
Rojan, Adam |
|
2013 |
11 |
3 |
p. 362-364 3 p. |
artikel |
6 |
Editorial Board
|
|
|
2013 |
11 |
3 |
p. A3- 1 p. |
artikel |
7 |
Effects of Serum Testosterone Levels After 6 Months of Androgen Deprivation Therapy on the Outcome of Patients With Prostate Cancer
|
Bertaglia, Valentina |
|
2013 |
11 |
3 |
p. 325-330.e1 2976 p. |
artikel |
8 |
High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium
|
Hainsworth, John D. |
|
2013 |
11 |
3 |
p. 283-289.e1 2608 p. |
artikel |
9 |
Iodine-125 Seed Implantation and Deferred Transurethral Resection of the Prostate for Patients With Lower Urinary Tract Symptoms and Localized Prostate Cancer
|
Liu, Ranlu |
|
2013 |
11 |
3 |
p. 251-255 5 p. |
artikel |
10 |
Long-Term Follow-Up Using Testicle-Sparing Surgery for Leydig Cell Tumor
|
Bozzini, Giorgio |
|
2013 |
11 |
3 |
p. 321-324 4 p. |
artikel |
11 |
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
|
Molina, Ana M. |
|
2013 |
11 |
3 |
p. 297-302 6 p. |
artikel |
12 |
Metabolic Syndrome as a Peculiar Target for Management of Prostate Cancer Patients
|
Conteduca, Vincenza |
|
2013 |
11 |
3 |
p. 211-220 10 p. |
artikel |
13 |
Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial
|
Hainsworth, John D. |
|
2013 |
11 |
3 |
p. 270-275 6 p. |
artikel |
14 |
Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity
|
Figg, William D. |
|
2013 |
11 |
3 |
p. 229-237 9 p. |
artikel |
15 |
Pooled Analysis of Phase II Trials Evaluating Weekly or Conventional Cisplatin as First-Line Therapy for Advanced Urothelial Carcinoma
|
Maughan, Benjamin L. |
|
2013 |
11 |
3 |
p. 316-320 5 p. |
artikel |
16 |
Preoperative Neutrophil-Lymphocyte Ratio as an Independent Prognostic Marker for Patients With Upper Urinary Tract Urothelial Carcinoma
|
Azuma, Takeshi |
|
2013 |
11 |
3 |
p. 337-341 5 p. |
artikel |
17 |
Prognostic Factors of Survival for Patients With Metastatic Renal Cell Carcinoma With Brain Metastases Treated With Targeted Therapy: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
|
Vickers, Michael M. |
|
2013 |
11 |
3 |
p. 311-315 5 p. |
artikel |
18 |
Prognostic Marker for Patients With Malignant Ureter Obstruction
|
Azuma, Takeshi |
|
2013 |
11 |
3 |
p. 353-356 4 p. |
artikel |
19 |
Prostate Cancer Detection by Using Digital Rectal Examination: Contemporary Practice Patterns in the United States
|
Tourville, Elizabeth A. |
|
2013 |
11 |
3 |
p. 263-269 7 p. |
artikel |
20 |
Pyuria Predicts Poor Prognosis in Patients With Non–Muscle-Invasive Bladder Cancer
|
Azuma, Takeshi |
|
2013 |
11 |
3 |
p. 331-336 6 p. |
artikel |
21 |
Response Evaluation Criteria in Solid Tumors Response of the Primary Lesion in Metastatic Renal Cell Carcinomas Treated With Sunitinib: Does the Primary Lesion Have to Be Regarded as a Target Lesion?
|
Park, Inkeun |
|
2013 |
11 |
3 |
p. 276-282 7 p. |
artikel |
22 |
Secondary Müllerian System: An Atypical Case of Tumor Originating From Vestigial Müllerian Cells Embedded in the Peritoneum
|
Berretta, Roberto |
|
2013 |
11 |
3 |
p. 365-369 5 p. |
artikel |
23 |
Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma
|
Yildiz, Ibrahim |
|
2013 |
11 |
3 |
p. 290-296 7 p. |
artikel |
24 |
Table of Contents
|
|
|
2013 |
11 |
3 |
p. A8-A12 nvt p. |
artikel |
25 |
The Impact of Gender on Outcomes in Patients With Metastatic Urothelial Carcinoma
|
Haines, Lindsay |
|
2013 |
11 |
3 |
p. 346-352 7 p. |
artikel |
26 |
The Role of p53 on Survival of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis
|
Ku, Ja Hyeon |
|
2013 |
11 |
3 |
p. 221-228 8 p. |
artikel |
27 |
Translocation Renal Cell Carcinomas: An Evolving Entity and a Member of the Microphthalmia Transcription Factor-Associated Family of Tumors
|
Bambury, Richard M. |
|
2013 |
11 |
3 |
p. 357-361 5 p. |
artikel |
28 |
Use of a Clinical Assistant to Screen Patients With Genitourinary Cancer to Encourage Entry into Clinical Trials and Use of Supportive Medication: A Pilot Project at a Canadian Cancer Center
|
Lun, Grace |
|
2013 |
11 |
3 |
p. 342-345.e1 3109 p. |
artikel |